COVAXIN : The trial of corona vaccine for children has started in India, which is expected to give positive results.
From today, the indigenous COVAXIN Trial on children of 6 to 12 years is starting.
Preparations are being made by the government to reduce the risk of third wave of Covid-19 for children. Under which trials of corona vaccine for children have started. Now the All India Institute of Medical Sciences (AIIMS) in Delhi is starting the trial of indigenous COVAXIN on children aged 6 to 12 years from today i.e. Tuesday. Children will first screened for the vaccine trial and then the trial will started on the basis of its report. Earlier, the trial of corona vaccine for children of 6 to 12 years has also started in AIIMS Patna.
Also Read – Sonam Kapoor looks gorgeous in Rs 1.4 lakh printed crop top and skirt; Check pictures
COVAXIN dose will given after the screening report
First the children’s screening report will awaited, from which it will found out whether Bharat Biotech’s COVAXIN will suitable for children or not. Earlier, Delhi AIIMS has finished the screening and trial of single dose COVAXIN on children aged 12 to 18 years. After India’s drug regulator allowed the trial of single-dose COVAXIN on children aged 2 to 18 years, the trial of COVAXIN on children age 12 to 18 years was start in Delhi AIIMS from June 7.
After 6 to 12 year old, AIIMS Delhi will also conduct trials on 2 to 6 year old. Let us tell you that experts have expressed the possibility of children becoming more infected in the third wave of corona. Due to which the whole world is starting the trial of corona vaccine on children. After the arrival of the corona vaccine for children, the third wave can prevented from coming.
Also Read – Akshay Kumar’s film ‘Bell Bottom’ will be released in July, fans were eagerly waiting for the film.